U.S. markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
201.32+1.07 (+0.53%)
Al cierre: 04:00PM EDT
202.78 +1.46 (+0.73%)
Fuera de horario: 04:41PM EDT

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo67,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Adam H. SchechterPresident, CEO & Chairman4.66MN/D1965
Mr. Glenn A. EisenbergCFO & Executive VP1.87MN/D1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1.43M129.25k1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer1.3MN/D1974
Ms. Anita Z. GrahamExecutive VP & Chief Human Resources Officer1.35MN/D1971
Mr. Peter J. WilkinsonSenior VP & Chief Accounting OfficerN/DN/D1972
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876.62kN/D1963
Christin O'DonnellVice President of Investor RelationsN/DN/DN/D
Ms. Sandra D. van der VaartExecutive VP, Chief Legal Officer, Chief Compliance Officer & Corporate SecretaryN/DN/D1960
Ms. Amy B. SummyExecutive VP & Chief Marketing OfficerN/DN/D1967
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Gestión corporativa

La calificación ISS Governance QuickScore de Laboratory Corporation of America Holdings a partir del 1 de mayo de 2024 es 3. Las puntuaciones principales son Auditoría: 6; Junta: 7; Derechos del accionista: 1; Compensación: 7.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.